Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Financial Advisors's IBB Position: Q3 2025 in Review
Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q3 2025 at 1,667 shares worth $241K. The position accounts for 0.04% of the portfolio, ranked #75.
Financial Advisors first reported a position in IBB in Q4 2018 and has held it in 28 quarters since. The position peaked at $370K in Q2 2021. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.
- Financial Advisors held 1,667 shares of iShares Biotechnology ETF worth $241K as of Q3 2025.
- Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q3 2025.
- iShares Biotechnology ETF made up 0.04% of Financial Advisors's portfolio in Q3 2025, its #75 holding.
- Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 28 quarters since.
- Financial Advisors's iShares Biotechnology ETF position peaked at $370K in Q2 2021.
- 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.
Based on Financial Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.